RLAY — Relay Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.19bn
- $2.55bn
- $15.36m
Advisory: Alert from Equity-Insider.com was published in error and has been withdrawn
Relay Therapeutics slightly misses Q3 net loss estimates, expects cash reserves to fund operations into 2029
Brief: Relay Therapeutics Q3 Net Income USD -74.149 Million Vs. IBES Estimate USD -73.9 Million
Relay Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Relay Therapeutics Q2 Net Income USD -70.375 Million
Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Brief: Relay Therapeutics Appoints Claire Mazumdar To Board Of Directors
Relay Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp
Relay Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Relay Therapeutics Q4 Net Income USD -76.004 Million
Relay Therapeutics Inc expected to post a loss of 56 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Gold miners, Tesla, ADM
U.S. STOCKS ON THE MOVE-Candel Therapeutics, Broadcom, Reddit
U.S. STOCKS ON THE MOVE-Exxon Mobil, Mondelez International, Macy's
U.S. STOCKS ON THE MOVE-General Motors, GE Vernova, Amazon
Relay Therapeutics rises on interim data for cancer drug
Relay Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary